Breaking Down CPT Technology (Group) Co.,Ltd Financial Health: Key Insights for Investors

Curious whether CPT Technology Co., Ltd. (000536.SZ) is a rebound story or a value trap? In Q2 2024 the company posted a striking $750 million in revenue - a 25% year‑over‑year jump from $600 million - with its semiconductor devices segment alone delivering $600 million in sales at a 38% gross margin, and Q2 net income rising to $150 million (up 30% YoY), yet these bright spots sit alongside alarming metrics such as a -65.3% net margin, TTM EPS of -0.40, a five‑year average earnings decline of -92.23% and a FY2024 net loss of -¥1.1 billion; balance sheet and market cues add complexity - market cap ≈ ¥13.8 billion, retained earnings ¥379.21 million, a calculated fair value of -¥2.00 vs current price ¥4.49 (upside -144.53%), and aggressive moves like major asset restructuring and 10% of revenue (~¥500 million in 2023) plowed into R&D - read on to unpack Revenue, Profitability, Debt, Liquidity, Valuation, Risks and Growth opportunities in depth.

CPT Technology Co.,Ltd (000536.SZ) - Revenue Analysis

• Q2 2024 total revenue: $750 million (YoY +25%).
• Semiconductor devices sales: $600 million; gross margin: 38%.
• Q2 2024 net income: $150 million (YoY +30%).
• Fiscal 2023 revenue: ¥5 billion; 2024 target: ¥6 billion.
• R&D spend: 10% of annual revenue - ¥500 million in 2023.

• The semiconductor devices segment accounted for 80% of Q2 2024 revenue ($600M of $750M).
• Non-semiconductor segments combined contributed $150M in Q2 2024.
• Consistent investment in R&D (¥500M in 2023) supports product mix expansion and margin preservation.

CPT Technology Co.,Ltd (000536.SZ) - Profitability Metrics

• Net margin (most recent): -65.3% - the company is losing ¥0.653 for every ¥1 of revenue as net income.
• EPS (TTM): -0.40 - negative earnings per share reflecting overall losses over the trailing twelve months.
• Five-year average earnings growth rate: -92.23% - a steep decline in earnings over the past five years.
• P/E ratio (as of 2025-10-27): -13.03 - negative earnings relative to market price, making standard P/E interpretation limited.
• Net income (FY2024): -¥1,100,000,000 - continued full-year negative profitability.
• Q2 2024 net income: +30% YoY improvement - a notable quarterly recovery versus the prior-year quarter despite still-negative absolute results.

CPT Technology Co.,Ltd (000536.SZ) - Debt vs. Equity Structure

CPT Technology's capital structure shows a sizable equity market value alongside recurring operating losses and active balance-sheet maneuvers. Key headline metrics and structural notes below give investors a focused view of leverage risk, equity buffer and recent strategic asset moves.

• Market capitalization: ¥13.8 billion (approx.), representing total equity value available to shareholders.
• Trailing twelve months (TTM) EPS: -0.40, indicating negative profitability per share.
• Net income (FY2024): -¥1.1 billion, continuing a multi-period loss trend that can weaken equity cushions against debt.
• Retained earnings (as of 30 June 2025): ¥379.21 million - accumulated profits (and losses) carried in equity.
• Debt-to-equity ratio: not explicitly provided in public figures; negative net income suggests potential stress in servicing and managing leverage.
• Major asset restructuring activity: acquisition of voting rights in other entities and other strategic transactions that reallocate assets and control.

Implications for investors include a trade-off between a ¥13.8 billion equity base and recurring losses that erode equity and complicate debt servicing; active restructuring (including acquiring voting rights) can alter leverage and control dynamics over short to medium term. For more on strategic orientation, see Mission Statement, Vision, & Core Values (2026) of CPT Technology (Group) Co.,Ltd.

CPT Technology Co.,Ltd (000536.SZ) - Liquidity and Solvency

CPT Technology (000536.SZ) shows strained liquidity and solvency metrics driven by ongoing negative profitability and major restructuring moves. Key headline figures for the latest reported period:

• Fiscal year 2024 net income: -¥1.10 billion
• Trailing twelve months (TTM) EPS: -0.40
• Net margin: -65.3% (loss equal to 65.3% of revenue)

Practical implications for creditors and investors:

• Negative net income and a -65.3% net margin point to operating losses substantially exceeding revenue, compressing internal cash generation.
• Implied revenue of ~¥1.685 billion provides scale context but highlights that losses are material relative to top line.
• Absence of disclosed operating cash flow makes it difficult to confirm whether losses are matched by cash burn or by non-cash charges; however, negative EPS and net loss increase probability of cash outflow from operations.
• Major asset restructuring typically requires both investing cash outflows (asset purchases, write-downs, or disposal costs) and financing activity (debt issuance, equity moves, or restructuring-related financing), raising short-term liquidity and solvency pressures.
• Key solvency watch items: ability to meet near-term maturities, covenant headroom on loans, and access to external financing during restructuring.

Selected near-term financial questions investors should monitor:

• Reported operating cash flow (next disclosure) - is it negative and by how much?
• Details and cash impact of the asset restructuring (one-time charges, proceeds, ongoing capex).
• Changes in debt levels or new financing arrangements to bridge cash shortfalls.
• Management guidance on path to profitability and timing for cash breakeven.

For background on company history and strategic context that may affect liquidity and restructuring rationale, see: CPT Technology (Group) Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

CPT Technology Co.,Ltd (000536.SZ) - Valuation Analysis

• Fair value (Peter Lynch) as of 2025-07-31: -¥2.00
• Market price: ¥4.49
• Calculated upside vs. fair value: -144.53% (implies market price well above calculated fair value)

• Negative EPS and P/E: EPS (TTM) = -0.40 produces a negative P/E (-13.03), signifying losses rather than earnings per share-based valuation.
• Severe net margin compression: Net margin of -65.3% indicates the company lost ¥0.653 for every ¥1 of revenue in the latest period.
• Large negative net income in 2024: FY 2024 net loss of ¥1.1 billion underscores persistent unprofitability driving negative valuation metrics.
• Price vs. model mismatch: Market price (¥4.49) far exceeds the negative fair value from the Peter Lynch approach, resulting in an implied downside when compared to that model.

CPT Technology Co.,Ltd (000536.SZ) - Risk Factors

• Net margin: -65.3% - the company loses ¥0.653 for every ¥1 of revenue.
• Trailing twelve months (TTM) EPS: -0.40, reflecting negative profitability per share.
• Five-year average earnings growth rate: -92.23%, indicating sustained earnings deterioration.
• Price-to-earnings (P/E) ratio (as of 2025-10-27): -13.03, driven by negative earnings versus market price.
• FY2024 net income: -¥1.1 billion, continuing a multi-year net loss trend.

• Earnings volatility: Large negative EPS and deep declines in earnings growth increase the risk of further dilution, debt financing, or equity raises.
• Valuation ambiguity: Negative P/E complicates traditional valuation comparisons and may reflect market pricing for recovery risk rather than current fundamentals.
• Liquidity and solvency pressure: Persistent net losses (‑¥1.1B in 2024) and steep negative margins raise concerns about cash burn and access to capital under strained market conditions.
• Operational and execution risk: Five-year earnings decline of -92.23% suggests structural or competitive challenges that must be addressed to return to profitability.
• Investor downside: Continued negative margins and EPS increase downside risk to equity holders, including potential for share price weakness or corporate actions.

CPT Technology Co.,Ltd (000536.SZ) - Growth Opportunities

• R&D commitment: invested ¥500 million in 2023, equal to 10% of 2023 annual revenue (¥5.0 billion).
• Top-line targets: management has set a 2024 revenue target of ¥6.0 billion (vs. ¥5.0 billion in 2023).
• Operational momentum: Q2 2024 revenue grew 25% year-over-year (vs. 20% YoY in Q2 2023), signaling accelerating demand.
• Profitability: Q2 2024 net income reached $150 million, a 30% increase year-over-year.
• Strategic moves: major asset restructuring completed, including acquisition of voting rights in related entities to consolidate control and drive synergies.

• R&D leverage: 10% reinvestment of revenue into R&D (¥500m) supports product pipeline, potential margin expansion and IP-based differentiation.
• M&A and governance: voting-rights acquisitions can accelerate vertical integration, stabilize supply chains and unlock cross-entity commercial opportunities.
• Scaling revenue: a ¥1.0 billion targeted increase for 2024 implies ~20% growth; if Q2 momentum sustains, upside to targets is plausible.
• Profit conversion: Q2 2024 net income growth (+30%) suggests operational gearing and margin improvement as revenues expand.